Engineered by BioPhotonix
Revolux photobiomodulation (rPBM) actively stimulates and repairs compromised retinal cells, helping to preserve central vision and maintain independence in patients with early and intermediate dry macular degeneration.
In just 8 minutes per session, our technology targets the root cause of decline to repair retinal health and protect sight. Whether accessed in a local optometry clinic or a supervised home visit, patients can finally gain the upper hand against dry macular degeneration—experiencing clearer vision, protected independence, and a renewed quality of life.
For your clinic, it seamlessly integrates hospital-grade care into routine workflows—turning unmet patient needs into a scalable, high-value revenue stream.
Designed for Clinical Impact
We replaced the fixed console with a precision binocular system that fits your workflow, not the other way around.​
Treat Early
Intervene when it matters most—before irreversible vision loss occurs.
​
Any Room, Any Time
Portable binocular design fits standard consulting rooms—no dedicated infrastructure required.
​
Precision Dosing
Unlike desktop systems, our 1-inch sensor technology guarantees exact source-to-eye geometry for every patient, every time.
Intelligent Delivery
​​Revolux combines biological optimisation with digital intelligence.
Multi-Layered Precision
We target the entire retinal structure. Revolux utilises a quad-wavelength array (595 - 880 nm) delivered through a precise hybrid of continuous and modulated light. This dual-action approach optimises cellular uptake at every depth—balancing steady mitochondrial activation with bioenergetic recovery.
​
Bio-Optimised Therapy
Standard devices just emit light. Revolux uses proprietary "Soft-Start" and stability algorithms to ensure the retina is metabolically prepared to receive treatment, maximising cellular response.
​
AI-Enabled Insight
Integrated AI instantly converts complex treatment data into clinician-ready reports and patient-friendly summaries, reducing administrative burden and boosting compliance.
Technology
You Can Trust
Revolux is built on a foundation of rigorous quality and regulatory compliance,
ensuring it meets the demands of modern healthcare environments.
Medical Device Validation
​
Developed under a certified ISO 13485 Quality Management System, Revolux is engineered to meet Class IIa medical device standards (UKCA/MDR), ensuring validated optical, electrical, and biological safety.
Active Safety Interlocks
​
The system utilises intelligent inhibition logic to guarantee safety.
Light emission is strictly prevented until sensors verify precise 1-inch alignment and physiological readiness, ensuring consistent, safe dosimetry every time.
Auditable Care
​
Unlike unsupervised consumer devices, Revolux is designed for accountability. Every treatment session is clinician-initiated and digitally logged, ensuring patients remain within a managed, traceable care pathway.